The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic and predictive significance of CA-125 elimination rate constant K (KELIM) in ovarian cancer patients treated with neoadjuvant chemotherapy in a real-world setting.
 
Michael Liontos
Employment - Pfizer (I)
Stock and Other Ownership Interests - Pfizer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Celgene; Ipsen; Janssen; MSD Oncology; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; GlaxoSmithKline; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Pfizer; Roche
 
Alkistis Papatheodoridi
No Relationships to Disclose
 
Elena Kunadis
No Relationships to Disclose
 
Anna Svarna
No Relationships to Disclose
 
Charalampos Theofanakis
No Relationships to Disclose
 
Oraianthi Fiste
No Relationships to Disclose
 
Angeliki Rouvali
No Relationships to Disclose
 
Kalliroi Goula
No Relationships to Disclose
 
Christos Markellos
No Relationships to Disclose
 
Angeliki Andrikopoulou
No Relationships to Disclose
 
Eirini Potiri
No Relationships to Disclose
 
Aristea-Maria Papanota
No Relationships to Disclose
 
Maria Kaparelou
No Relationships to Disclose
 
Konstantinos Koutsoukos
No Relationships to Disclose
 
Nikolaos Thomakos
No Relationships to Disclose
 
Dimitrios Haidopoulos
No Relationships to Disclose
 
Alexandros Rodolakis
No Relationships to Disclose
 
Flora Zagouri
Honoraria - Lilly O.; Novartis; Roche Canada
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech; SEAGEN
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda